MaxCyte, Inc. (MXCT)
NASDAQ · Healthcare
MaxCyte, Inc. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 21.0M | 22.2M | 19.5M | 28.7M | 21.6M | 15.5M | 13.3M |
| Gross Profit | 26.8M | 31.5M | 36.5M | 39.2M | 30.2M | 23.4M | 19.1M |
| Profitability | |||||||
| Operating Income | -51.9M | -51.2M | -48.3M | -27.4M | -18.2M | -11.1M | -12.4M |
| EBITDA | — | — | — | — | — | — | — |
| Net Income | -44.6M | -41.1M | -37.9M | -23.6M | -19.1M | -11.8M | -12.9M |
| Per Share Data | |||||||
| EPS (diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 106M | 105M | 103M | 102M | 91M | 69M | 56M |
MaxCyte, Inc. Income Statement — FAQ
MaxCyte, Inc. (MXCT) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MXCT's income statement history?
The chart and table above show MaxCyte, Inc.'s income statement by year and by quarter, including the growth rate.